Back
40
Day Range
$193.81
$197.03
52-Week Range
$157.20
$213.50
Volume
384,942
50D / 200D Avg
$195.42
/
$183.46
Prev Close
$195.60
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 22.0 | 0.4 |
| P/B | 3.0 | 2.9 |
| ROE % | 14.2 | 3.7 |
| Net Margin % | 9.0 | 3.9 |
| Rev Growth 5Y % | 0.6 | 10.0 |
| D/E | 1.0 | 0.2 |
Analyst Price Target
Hold
$215.10
+9.7%
Low: $200.00
High: $235.00
Forward P/E
18.4
Forward EPS
$10.64
EPS Growth (est.)
+0.0%
Est. Revenue
12 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$13.89
$13.50 – $14.19
|
13 B | 2 |
| FY2028 |
$12.49
$11.82 – $13.50
|
13 B | 7 |
| FY2027 |
$11.47
$11.22 – $11.85
|
12 B | 12 |
Key Takeaways
Revenue grew 0.57% annually over 5 years — modest growth
ROE of 14.22% — decent returns on equity
Generating 1.36B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11.21%
Cash machine — converts 137.00% of earnings into free cash flow
Capital efficient — spends only 4.78% of revenue on capex
Growth
Revenue Growth (5Y)
0.57%
Revenue (1Y)11.78%
Earnings (1Y)13.89%
FCF Growth (3Y)25.42%
Quality
Return on Equity
14.22%
ROIC8.53%
Net Margin8.99%
Op. Margin14.53%
Safety
Debt / Equity
0.96
Current Ratio1.04
Interest Coverage6.07
Valuation
P/E Ratio
21.99
P/B Ratio3.04
EV/EBITDA17.66
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.78% | Revenue Growth (3Y) | 9.21% |
| Earnings Growth (1Y) | 13.89% | Earnings Growth (3Y) | 7.78% |
| Revenue Growth (5Y) | 0.57% | Earnings Growth (5Y) | -16.03% |
| Profitability | |||
| Revenue (TTM) | 11.04B | Net Income (TTM) | 992.00M |
| ROE | 14.22% | ROA | 6.11% |
| Gross Margin | 31.93% | Operating Margin | 14.53% |
| Net Margin | 8.99% | Free Cash Flow (TTM) | 1.36B |
| ROIC | 8.53% | FCF Growth (3Y) | 25.42% |
| Safety | |||
| Debt / Equity | 0.96 | Current Ratio | 1.04 |
| Interest Coverage | 6.07 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 21.99 | P/B Ratio | 3.04 |
| P/S Ratio | 1.98 | PEG Ratio | 1.42 |
| EV/EBITDA | 17.66 | Dividend Yield | 0.02% |
| Market Cap | 21.81B | Enterprise Value | 28.31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.04B | 9.87B | 9.25B | 9.88B | 10.79B |
| Net Income | 992.00M | 871.00M | 854.00M | 946.00M | 2.00B |
| EPS (Diluted) | 8.75 | 7.69 | 7.52 | 7.98 | 15.53 |
| Gross Profit | 3.52B | 3.24B | 3.07B | 3.43B | 4.21B |
| Operating Income | 1.60B | 1.35B | 1.26B | 1.43B | 2.38B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 16.23B | 16.15B | 14.02B | 12.84B | 13.61B |
| Total Liabilities | 8.94B | 9.26B | 7.60B | 6.83B | 7.05B |
| Shareholders' Equity | 7.17B | 6.78B | 6.31B | 5.89B | 6.44B |
| Total Debt | 6.92B | 7.09B | 5.50B | 4.71B | 4.77B |
| Cash & Equivalents | 420.00M | 549.00M | 686.00M | 315.00M | 872.00M |
| Current Assets | 2.38B | 2.39B | 2.37B | 1.90B | 2.74B |
| Current Liabilities | 2.28B | 2.17B | 1.82B | 1.55B | 1.75B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#614 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026